Sergio A. A.
- Country
- Spain
- Department
- Pediatrics
Research Overview
- A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Clemizole Hydrochloride as Adjunctive Therapy in Patients with Lennox-Gastaut Syndrome
- Evaluation of Perampanel as Adjunctive Therapy in Pediatric Patients with Childhood Epilepsy: An Open-Label Study with Extension Phase
- Efficacy and Safety of Bexicaserin in Seizure Management for Pediatric and Adult Dravet Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 43 of 77 partner sites.
Specializations
Pediatric Neurology
The investigator specializes in treating childhood neurological disorders, with particular expertise in managing various forms of epilepsy syndromes and rare neurological conditions.
- Dravet Syndrome
- Childhood Epilepsy
- Seizure Management
Their clinical focus encompasses comprehensive treatment approaches for children with complex neurological conditions requiring specialized care.
Therapeutic Management
The investigator has developed expertise in antiepileptic medication management, focusing on innovative therapeutic approaches for treatment-resistant epilepsy cases.
- Novel Anticonvulsant Therapies
- Combination Treatment Strategies
- Long-term Seizure Control
Their work involves evaluating new therapeutic options for patients with challenging neurological conditions.
Clinical Assessment
The investigator employs advanced methods for seizure frequency assessment and response monitoring in pediatric epilepsy patients.
- Treatment Response Evaluation
- Motor Seizure Analysis
- Clinical Outcomes Assessment
Their expertise includes precise measurement of therapeutic efficacy in complex neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.